...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith MD&A and Financials are up

I got the reports in the mail last week.  The financial situation depicted in the report is not good.

Share
New Message
Please login to post a reply